Which has grown faster, INSP or RXRX?

Over the past five years, RXRX grew revenue faster — INSP at a 38.69% CAGR versus RXRX at 45.50%.

Is INSP or RXRX more profitable?

INSP runs the higher net margin — INSP at 15.03% versus RXRX at -945.92%.

How have INSP and RXRX total returns compared?

Over the past 5 years, INSP delivered -21.78% and RXRX delivered -28.37% annualized total return. Past performance doesn't predict future results.

Inspire Medical Systems, Inc. (INSP) vs Recursion Pharmaceuticals, Inc. (RXRX)

A side-by-side comparison of Inspire Medical Systems, Inc. and Recursion Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.

INSP

Inspire Medical Systems, Inc.

$2.02B

$69.97HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

RXRX

Recursion Pharmaceuticals, Inc.

$2.16B

$4.12HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — INSP vs RXRX

growth of $100 · dividends reinvested · last 5y

INSP -68.9% (-20.8%/yr)RXRX -77.1% (-25.5%/yr)INSP compounded faster over this window

INSP RXRX

INSP vs RXRX: by the numbers

•RXRX is the larger company ($2.16B vs $2.02B market cap).
•INSP is profitable (15.03% net margin) while RXRX runs a net loss (-945.92%).
•RXRX grew revenue faster over the past five years (45.50% vs 38.69% CAGR).

Metrics side by side

Valuation

Metric	INSP	RXRX
P/E ratio	15.14	N/A
Forward P/E	58.58	N/A
P/S ratio	2.25	39.41
P/B ratio	2.45	2.36
EV / EBITDA	26.98	N/A
FCF yield	5.79%	N/A

Profitability

Metric	INSP	RXRX
Gross margin	86.13%	-61.96%
Operating margin	6.02%	-867.87%
Net margin	15.03%	-945.92%
ROE	16.36%	-56.71%
ROIC	6.33%	-49.78%

Growth (annualized)

Metric	INSP	RXRX
Revenue CAGR (5Y)	38.69%	45.50%
Total return CAGR (5Y)	-21.78%	-28.37%

Frequently asked

Which has grown faster, INSP or RXRX?: Over the past five years, RXRX grew revenue faster — INSP at a 38.69% CAGR versus RXRX at 45.50%.
Is INSP or RXRX more profitable?: INSP runs the higher net margin — INSP at 15.03% versus RXRX at -945.92%.
How have INSP and RXRX total returns compared?: Over the past 5 years, INSP delivered -21.78% and RXRX delivered -28.37% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INSP analysis Full RXRX analysis Interactive comparison tool

Dig into the metrics

Inspire Medical Systems P/E ratio Inspire Medical Systems ROE Recursion Pharmaceuticals ROE Inspire Medical Systems operating margin Recursion Pharmaceuticals operating margin Inspire Medical Systems revenue growth Recursion Pharmaceuticals revenue growth Inspire Medical Systems free cash flow Recursion Pharmaceuticals free cash flow

Inspire Medical Systems & Recursion Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.